• National Cancer Institute
  • National Human Genome Research Institute

History and Timeline

November 17-18, 2011
TCGA holds its First Annual Scientific Symposium

November 1, 2011
NHGRI Genome Sequencing Centers receive next round of funding and continued support for TCGA sequencing efforts

October 20, 2011
TCGA ships milestone 5,000th case to centers

July 2011
TCGA Researchers Report the Findings of their Comprehensive Characterization of the Ovarian Cancer Genome

February 2011
TCGA Scientists Discover Four Distinct Subtypes of Glioblastoma Distinguished by Gene Expression Patterns and Clinical Characteristics

April 15, 2010
TCGA Identifies Novel Molecular Subtype in Brain Cancer Patients with Distinct Clinical Features

January 19, 2010
TCGA Identifies Distinct Subtypes of Deadly Brain Cancer That May Lead to New Treatment Strategies

October 2009
Recovery Act Investment Enables The Cancer Genome Atlas To Map 20 Cancers

June 2009
Genome Sequencing Centers begin including second generation sequencing data in the TCGA pipeline, including whole exome and whole genome data

March 2009
Genome Sequencing Centers shift from sequencing 601 genes to hybrid capture methods targeting more than 6,000 gene and miRNA sequences

February 16, 2009
Molecular characterization data become available at the Data Coordinating Center for ovarian cancer samples

September 4, 2008
TCGA reports first results of comprehensive study of glioblastoma multiforme

April 2008
Revised informed consent policies established

July 17, 2007
First upload of data from the Cancer Genome Characterization Centers to the Data Coordinating Center

July 2, 2007
TCGA awards funds for technology development

November 20, 2006
National Human Genome Research Institute announces funding for large-scale Genome Sequencing Centers

October 16, 2006
NIH announces components of TCGA pilot project

September 13, 2006
NIH announces plans to map genomic changes of lung, brain and ovarian cancers

December 13, 2005
NIH launches comprehensive effort to explore genomic alterations in human tumors